Cannabis Central: Only these 12 Cannabis Stocks are Higher YTD

These cannabis “momentum” stocks are up 24.6% this year

Below is an article written by Lorimer Wilson of Munknee.com. MunKNEE.com is a new affiliate of eResearch.com.

//

This article highlights the performance of the 12 “momentum” stocks within the Non-penny Pot Stock Index which, given that they represent only 4% of all cannabis stocks, certainly warrant your consideration.

  • 298 cannabis stocks trade on the various Canadian and American stock exchanges and they, collectively, are DOWN 25.9% YTD (as of close of trading on June 5th)
  • 39 of those 298 (i.e. 13%) are non-penny stocks (i.e. trading actively and consistently above US$1/share) which make up the constituents of the Non-penny Pot Stock Index (NPSI) and they are DOWN 4%, on average, YTD (Source)
  • 12 of those 39 are ‘momentum” stocks given that they are UP 24.6% YTD

Given the above you can understand my concentration on the very few winners in the cannabis stock sector. The details of their performance, in descending order, are as follows:

  1. XPhyto(XPHYF) +213.3% YTD
  2. GrowGeneration(GRWG) +60.0% YTD
  3. Rubicon(ROMJ) +29.0% YTD
  4. Corbus(CRBP) +26.6% YTD
  5. Akerna(KERN) +26.5% YTD
  6. Innovative Properties(IIPR) +20.2% YTD
  7. GW Pharma(GWPH) +16.2% YTD
  8. Abacus+10.0% YTD
  9. Columbia(CCHWF) +10.0%YTD
  10. Trulieve(TCNNF) +3.9% YTD
  11. Greenlane(GNLN) +3.7% YTD
  12. Terrascend (TRSSF) N/C YTD

//

To view the original article, please visit https://www.munknee.com/cannabis-central-only-these-12-pot-stocks-out-of-298-are-up-ytd/

//

munKNEE.com is a new affiliate of eResearch.com. To learn more about munKNEE.com, please visit their website and sign-up for their weekly newsletter.

//

About Chris Thompson 350 Articles
Chris Thompson is the President and Director of Equity Research at eResearch. He is a Professional Engineer and CFA Charterholder with a MBA in Investment Management and over 15 years of experience in software development, FinTech, telecommunications, and information technology. For the past 10 years, he has worked in the Capital Markets in Equity Research, M&A Investment Banking and Consulting in various sectors.